Literature DB >> 167656

Physiological and pharmacological roles of prostaglandins.

P J Kadowitz, P D Joiner, A L Hyman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167656     DOI: 10.1146/annurev.pa.15.040175.001441

Source DB:  PubMed          Journal:  Annu Rev Pharmacol        ISSN: 0066-4251            Impact factor:   13.820


× No keyword cloud information.
  9 in total

1.  Prostaglandins and ocular inflammation.

Authors:  D W Hall; I L Bonta
Journal:  Doc Ophthalmol       Date:  1977-12-30       Impact factor: 2.379

2.  Reactivity of isolated canine bronchus and pulmonary blood vessels to autonomic, autacoid agents and antigen.

Authors:  N Chand; P Eyre
Journal:  Agents Actions       Date:  1979-04

3.  Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.

Authors:  J T Zakrzewski; N C Barnes; P J Piper; J F Costello
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

4.  Variability of the pulmonary vascular response to hypoxia and relation to gas exchange in dogs.

Authors:  J B Forrest; A Fargas-Babjak
Journal:  Can Anaesth Soc J       Date:  1978-11

5.  Differential effects of prostaglandins on canine intrapulmonary arteries and veins.

Authors:  B M Altura; N Chand
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

6.  E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin.

Authors:  J R Fletcher; P W Ramwell
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

Review 7.  Type II pseudohypoaldosteronism. Report of a case and review of the literature.

Authors:  S Muhammad; Z M Mamish; J R Tucci
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

8.  Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog.

Authors:  J R Fletcher; P W Ramwell
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

9.  Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.

Authors:  N J Dodd; M P Gordge; M J Weston
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.